10 June 2024
Oxford Nanopore Technologies plc
(the "Company")
Results of Annual General Meeting; Changes to Director Roles and Responsibilities
The Annual General Meeting of the Company was held earlier today. All resolutions, as set out in the Company's Notice of Annual General Meeting dated 30 April 2024, were passed by the appropriate majority on a poll. Details of the poll results are set out below.
Oxford Nanopore Technologies plc Annual General Meeting Poll Results
No. | RESOLUTION | VOTES | % | VOTES | % | VOTES | % of ISC VOTED | VOTES |
1. | To receive the Directors' Report, the Audited Statement of Accounts and Auditor's Report of the Company for the financial year ended 31 December 2023
| 469,892,189 | 99.99% | 26,641 | 0.01% | 469,918,830 | 54.46 | 311,222 |
2. | To approve the Directors' Remuneration Report for the year ended 31 December 2023 | 465,905,694 | 99.12% | 4,143,296 | 0.88% | 470,048,990 | 54.48 | 181,062 |
3. | To elect Dr Sarah Fortune as a director of the Company | 466,325,259 | 99.18% | 3,849,452 | 0.82% | 470,174,711 | 54.49 | 55,341 |
4. | To elect Nicholas Keher as a director of the Company | 469,870,281 | 99.97% | 162,771 | 0.03% | 470,033,052 | 54.48 | 197,000 |
5. | To elect Dr Heather Preston as a director of the Company | 466,322,469 | 99.21% | 3,709,228 | 0.79% | 470,031,697 | 54.48 | 198,355 |
6. | To elect Katherine (Kate) Priestman as a director of the Company | 466,300,925 | 99.18% | 3,861,923 | 0.82% | 470,162,848 | 54.49 | 67,204 |
7. | To re-elect Dr Guy Harmelin as a director of the Company | 464,917,610 | 98.91% | 5,104,486 | 1.09% | 470,022,096 | 54.47 | 207,956 |
8. | To re-elect Adrian Hennah as a director of the Company | 460,470,500 | 97.94% | 9,680,162 | 2.06% | 470,150,662 | 54.49 | 79,390 |
9. | To re-elect John O'Higgins as a director of the Company | 464,999,629 | 99.59% | 1,908,185 | 0.41% | 466,907,814 | 54.11 | 3,322,238 |
10. | To re-elect Dr Gurdial (Gordon) Sanghera as a director of the Company | 461,914,297 | 98.45% | 7,270,009 | 1.55% | 469,184,306 | 54.38 | 1,045,746 |
11. | To re-elect Duncan Tatton-Brown as a director of the Company | 464,847,803 | 98.87% | 5,309,918 | 1.13% | 470,157,721 | 54.49 | 72,331 |
12. | To appoint Deloitte LLP as auditors of the Company | 466,464,788 | 99.20% | 3,738,930 | 0.80% | 470,203,718 | 54.50 | 26,334 |
13. | To authorise the Audit & Risk Committee to determine the remuneration of the auditors | 466,575,139 | 99.23% | 3,628,978 | 0.77% | 470,204,117 | 54.50 | 25,935 |
14. | To authorise the Directors to allot shares | 460,676,251 | 97.98% | 9,509,239 | 2.02% | 470,185,490 | 54.49 | 44,562 |
15. | To disapply pre-emption rights* | 464,705,201 | 98.83% | 5,484,342 | 1.17% | 470,189,543 | 54.49 | 40,509 |
16. | To further disapply pre-emption rights* | 445,793,600 | 94.81% | 24,398,368 | 5.19% | 470,191,968 | 54.49 | 38,084 |
17. | To authorise the Company to make market purchases* | 469,870,163 | 99.94% | 284,177 | 0.06% | 470,154,340 | 54.49 | 75,712 |
18. | To authorise the Company to hold any general meeting (other than an Annual General Meeting) on not less than 14 clear days' notice* | 464,596,748 | 98.80% | 5,622,100 | 1.20% | 470,218,848 | 54.50 | 11,204 |
19. | To authorise UK political expenditure not exceeding £100,000 | 465,736,594 | 99.09% | 4,299,448 | 0.91% | 470,036,042 | 54.48 | 194,010 |
*Special Resolution
NOTES:
1. Votes "For" and "Against" are expressed as a percentage of votes received.
2. The total number of ordinary shares in issue and eligible to be voted on at the AGM was 862,829,513.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution nor in the calculation of the proportion of "Total issued share capital voted" for any resolution.
In accordance with Listing Rule 9.6.2, a copy of the resolutions will shortly be submitted to the National Storage Mechanism and will be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
A copy of the poll results for the AGM will also be available shortly on the Company's website at https://nanoporetech.com/about-us/investors/shareholder-information.
Director Roles and Responsibilities
In accordance with UK Listing Rule 9.6.11(3), the Company announces that John O'Higgins, a Non-Executive Director, has been appointed Chair of the Remuneration Committee on an interim basis with effect from today.
As previously disclosed, Tim Cowper, Dr Spike Willcocks, and Wendy Becker, the previous Chair of the Remuneration Committee, stepped down from the Board at the conclusion of the Company's Annual General Meeting earlier today.
-ENDS-
Enquiries:
Hannah Coote, Company Secretary
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.